Irinotecan Hydrochloride Trihydrate Pharmaceutical Raw Drug

» pharmazeutisch » Anti-Tumor-Medikamente » Irinotecan Hydrochloride Trihydrate Pharmaceutical Raw Drug

  • Spezifikationen

Buy Irinotecan Hydrochloride Trihydrate Pharmaceutical Raw Anti-tumor Drugs Online

 

Irinotecan Hydrochloride Trihydrate Specification

Produktname: Irinotecan Hydrochloride Trihydrate
CAS: 136572-09-3
Niveau: Pharmazeutische Klasse
Inhalt: 99%
Aussehen: weißes Puder
Number of meshes:80 mesh
Verpackung: 500G / Aluminium-Folienbeutel
Kategorie: Plant Extracts
Feld: Pharmaceuticals
Deferred products: irinotecan hydrochloride tablets; irinotecan hydrochloride injection
Benutzen: For patients with advanced colorectal cancer, combined with 5-fluorouracil and folinic acid in patients with advanced colorectal cancer who have not received chemotherapy before, as a single medication, to treat patients who failed treatment with 5-fluorouracil chemotherapy
Usage and dosage: 1 A method for small cell lung cancer and non-small cell lung cancer, B method for cervical cancer and ovarian cancer. A method: adult 100mg/m2, intravenous drip, 1 week interval and then repeat the intravenous infusion, 3 zu 4 times for a course of treatment. At least two weeks before the next course of treatment. Need to repeat a few courses. B method: 150 mg/m2, 1 intravenous drip, withdrawal for 2 weeks. Repeat 2 or 3 times in this way as a course of treatment, at least 3 weeks before stopping treatment for the next course of treatment. This method can be repeated. The dose may be appropriately increased or decreased according to age, weight, and condition. 2 When this product is used, it needs to be mixed with more than 500ml of physiological saline, glucose solution or electrolyte infusion agent, and then slowly instill for more than 90 minutes.

 

Irinotecan Hydrochloride Trihydrate Certificate of Analysis

Produktname Irinotecan Hydrochloride Trihydrate
CAS-Nr. 100286-90-6 äußere Verpackung 25kg / drum
Produktionsdatum Sep, 28, 2017 Haltbarkeit Sep, 27, 2019
Standard, der Unternehmensstandard
Elemente der Analyse Spezifikation Ergebnisse
ASSAY (on dried basis) 98.0%–102.0% 99.8%
CHARACTERS Light yellow or almost yellow,crystalline powder and odorless. Konform
IDENTIFICATION Infrared Absorption:In accordance with the reference Standard spectrum of Irinotecan Hydrochloride. Konform
RESIDUE ON IGNITION NMT 0.1 % 0.07 %
HEAVY METALS NMT 0.001 % <0.001%
WATER(K.F) 7.0 %—9.0 % 8.3 %
RELATED COMPOUNDS (HPLC) (on dried basis) 11-Ethyl irinotecanc≤0.15%

7,11-Diethyl-10-hydroxycamptothecing≤0.15%

Undetected

Undetected

Schlussfolgerung Qualifizierte

 

Sales Contacts

Tel/Whatsapp: +86 17707567122
Wickr: mollyying
Telegramm: +86 185785209851
Skype: ying_2073
Mail: ying@wumeitech.com

Anfrageformular ( wir werden wieder so schnell wie möglich erhalten )

Name:
*
Email:
*
Botschaft:

Nachprüfung:
0 + 4 = ?

Vielleicht gefällt Ihnen auch

  • Produktkategorien

  • kürzliche Posts

  • Aktie